Ted Witek

Since his retirement in 2014 from Boehringer Ingelheim Canada where he was President and CEO, Ted has taken on the role as a healthcare advisor and scholar based in Toronto (ON) and Lisbon (PT). His is a Professor and Senior Fellow at University of Toronto’s School of Public Health. Ted has earned a BSc from Quinnipiac College, an MPH from Yale, his DrPH from Columbia in NYC and MBA from Henley in London (UK). He has published over 100 manuscripts and chapters in respiratory and drug development area; he has expertise in obstructive airway disease and has been a major contributor to the field of cough, cold & allergy.

Ted joined the Trudell Board in 2014.